India
# |
Name |
Receivables |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 577.48 M
|
March 31, 2024 | USD 13.57 | -0.25% |
|
India |
|
2 |
USD 222.81 M
|
March 31, 2024 | USD 17.54 | 2.44% |
|
India |
|
3 |
USD 74.09 M
|
March 31, 2024 | USD 18.21 | -3.37% |
|
India |
|
4 |
USD 26.62 M
|
March 31, 2024 | USD 25.14 | -2.56% |
|
India |
|
5 |
USD 10.43 M
|
March 31, 2024 | USD 11.74 | -1.33% |
|
India |
|
6 |
USD 9.43 M
|
March 31, 2024 | USD 21.37 | -1.96% |
|
India |
|
7 |
USD 6.88 M
|
March 31, 2024 | USD 4.72 | -3.66% |
|
India |
The Vaccines company in India with the highest Receivables is Aurobindo Pharma Limited (NSE: AUROPHARMA.NS) at USD 577.48 M.
The Vaccines company in India with the lowest Receivables is Panacea Biotec Limited (NSE: PANACEABIO.NS) at USD 6.88 M.
The top 10 Vaccines companies in India by Receivables are Aurobindo Pharma Limited, Glenmark Pharmaceuticals Limited, Wockhardt Limited, GlaxoSmithKline Pharmaceuticals Limited, Vimta Labs Limited, Hester Biosciences Limited and Panacea Biotec Limited.
The bottom 10 Vaccines companies in India by Receivables are Panacea Biotec Limited, Hester Biosciences Limited, Vimta Labs Limited, GlaxoSmithKline Pharmaceuticals Limited, Wockhardt Limited, Glenmark Pharmaceuticals Limited and Aurobindo Pharma Limited.